Volume 136, Issue 4 pp. 977-981
Short Report

Absence of cytomegalovirus in high-coverage DNA sequencing of human glioblastoma multiforme

Ka-Wei Tang

Ka-Wei Tang

Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, SE-405 30 Gothenburg, Sweden

Search for more papers by this author
Kristoffer Hellstrand

Kristoffer Hellstrand

Department of Infectious Diseases, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, SE-405 30 Gothenburg, Sweden

Search for more papers by this author
Erik Larsson

Corresponding Author

Erik Larsson

Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, SE-405 30 Gothenburg, Sweden

Correspondence to: Erik Larsson, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, SE-405 30 Gothenburg, Sweden, Tel.: +[46-31-786-6942], Fax: +[46-31-41-61-08], E-mail: [email protected]Search for more papers by this author
First published: 24 June 2014
Citations: 32

Abstract

Cytomegalovirus (CMV) has been proposed to be associated with glioblastoma multiforme, but there are conflicting results including lack of CMV mRNA in transcriptome sequencing data. Here, we utilized deep-coverage whole-genome sequencing data to detect latent CMV DNA in surgically resected tumors and to assess the relative proportions of viral and human DNA. We did not find traces of CMV in 52.6 billion DNA sequencing reads from 34 glioblastomas. By statistical analysis, we conclude that should the virus be present in these tumors, the average CMV level does not exceed one virus per 240,000 tumor cells (99% CI).

Abstract

What's new?

While cytomegalovirus (CMV) has been functionally implicated in glioblastoma, its presence has been challenged by several reports, including lack of CMV mRNA in transcriptome studies. Here, the authors utilized deep-coverage whole-genome sequencing data to detect CMV DNA in surgically resected tumors. They found no traces of CMV in 52.6 billion DNA sequencing reads from 34 glioblastomas. Based on statistical analysis, they conclude that should the virus be present in these tumors, the average CMV level does not exceed one virus per 240,000 tumor cells (99% CI), effectively settling any remaining controversies regarding widespread presence of CMV DNA in glioblastoma.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.